A - AGILENT TECHNOLOGIES, INC.

120.54
1.500   1.244%

Share volume: 2,805,011
Last Updated: 03-04-2026
Measuring And Control Equipment/Lab Analytical Instruments: -0.04%

PREVIOUS CLOSE
CHG
CHG%
$119.04
1.50
0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
59%
Profitability 63%
Dept financing 29%
Liquidity 75%
Performance 58%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-1.93%
1 Month
-10.48%
3 Months
-19.74%
6 Months
-7.35%
1 Year
-3.27%
2 Year
-16.67%
Key data
Stock price
$120.54
P/E Ratio 
31.84
DAY RANGE
$119.25 - $121.17
EPS 
$4.59
52 WEEK RANGE
$96.43 - $160.27
52 WEEK CHANGE
-$5.90
MARKET CAP 
41.493 B
YIELD 
0.68%
SHARES OUTSTANDING 
283.499 M
DIVIDEND
$0.255
EX-DIVIDEND DATE
03-31-2026
NEXT EARNINGS DATE
08-20-2025
BETA 
0.68
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$3,456,160
AVERAGE 30 VOLUME 
$2,596,195
Company detail
CEO: Michael R. McMullen
Region: US
Website: agilent.com
Employees: 18,100
IPO year: 1999
Issue type: Common Stock
Market: NYSE
Industry: Measuring And Control Equipment/Lab Analytical Instruments
Sector: Manufacturing

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, and genetic data management.

Recent news